SCHEMBL1009960

SCHEMBL1009960

C[n+]1ccn(Cc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 3/20 0.42
PON1 P27169 1/20 0.39
P2RX3 P56373 1/20 0.38
CHKA P35790 1/20 0.38
TAAR1 Q96RJ0 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
IDO1 P14902 1/20 0.36
MEN1 O00255 1/20 0.36
APAF1 O14727 1/20 0.36
NPC1 O15118 1/20 0.36
PLA2G1B P04054 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2191910 0.98 KDM4E (0.41) KDM4EALDH1A1PON1P2RX3CHKA
SCHEMBL16674128 0.86 PON1 (0.46) ALDH1A1PON1SMN1; SMN2MEN1APAF1
SCHEMBL12220255 0.81 PON1 (0.43) PON1CHKASMN1; SMN2MEN1APAF1
Bromide SCHEMBL2192405 0.81 ALDH1A1 (0.47) KDM4EALDH1A1TAAR1SMN1; SMN2IDO1
SCHEMBL16638701 0.80 CYP19A1 (0.47) ALDH1A1PON1SMN1; SMN2IDO1MEN1
Iodide SCHEMBL2527838 0.80 PON1 (0.42) PON1SMN1; SMN2MEN1APAF1NPC1
SCHEMBL12513967 0.78 CYP11B1 (0.46) ALDH1A1PON1SMN1; SMN2MEN1APAF1
SCHEMBL667065 0.78 PON1 (0.50) PON1SMN1; SMN2MEN1APAF1NPC1
SCHEMBL31238837 0.77 PON1 (0.47) PON1SMN1; SMN2MEN1APAF1NPC1
Iodide SCHEMBL13735543 0.77 PON1 (0.40) ALDH1A1PON1SMN1; SMN2MEN1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268652-B1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-12-19 EP disclosed
EP-2268652-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-01-05 EP disclosed
WO-2009118475-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed